title: Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma.
abstract: Elevated cytokines in bone marrow (BM) micro-environment (interleukin-6 [IL-6], transforming growth factor-beta [TGF-beta], and IL-1beta) may play an important role in observed immune dysfunction in multiple myeloma (MM). As IL-6 and TGF-beta are important for the generation of T-helper 17 (T(H)17) cells, we evaluated and observed a significantly elevated baseline and induced frequency of T(h)17 cells in peripheral blood mononuclear cells (PBMCs) and BM mononuclear cells (BMMCs) from MM patients compared with healthy donors. We observed significant increase in levels of serum IL-17, IL-21, IL-22, and IL-23 in blood and BM in MM compared with healthy donors. We also observed that myeloma PBMCs after T(H)17 polarization significantly induced IL-1alpha, IL-13, IL-17, and IL-23 production compared with healthy donor PBMCs. We next observed that IL-17 promotes myeloma cell growth and colony formation via IL-17 receptor, adhesion to bone marrow stromal cells (BMSCs) as well as increased growth in vivo in murine xenograft model of human MM. Additionally, we have observed that combination of IL-17 and IL-22 significantly inhibited the production of T(H)1-mediated cytokines, including interferon-gamma (IFN-gamma), by healthy donor PBMCs. In conclusion, IL-17-producing T(h)17 cells play an important role in MM pathobiology and may be an important therapeutic target for anti-MM activity and to improve immune function.
authors.affiliation: Veterans Administration Boston Healthcare System, West Roxbury, MA;
authors.forename: Rao H
authors.initials: RH
authors.lastname: Prabhala
authors.forename: Dheeraj
authors.initials: D
authors.lastname: Pelluru
authors.forename: Mariateresa
authors.initials: M
authors.lastname: Fulciniti
authors.forename: Harsha K
authors.initials: HK
authors.lastname: Prabhala
authors.forename: Puru
authors.initials: P
authors.lastname: Nanjappa
authors.forename: Weihua
authors.initials: W
authors.lastname: Song
authors.forename: Christine
authors.initials: C
authors.lastname: Pai
authors.forename: Samir
authors.initials: S
authors.lastname: Amin
authors.forename: Yu-Tzu
authors.initials: YT
authors.lastname: Tai
authors.forename: Paul G
authors.initials: PG
authors.lastname: Richardson
authors.forename: Irene M
authors.initials: IM
authors.lastname: Ghobrial
authors.forename: Steven P
authors.initials: SP
authors.lastname: Treon
authors.forename: John F
authors.initials: JF
authors.lastname: Daley
authors.forename: Kenneth C
authors.initials: KC
authors.lastname: Anderson
authors.forename: Jeffery L
authors.initials: JL
authors.lastname: Kutok
authors.forename: Nikhil C
authors.initials: NC
authors.lastname: Munshi
mesh_terms: D000818:Animals; D049109:Cell Proliferation; D016207:Cytokines / Q000276:immunology; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D020381:Interleukin-17 / Q000276:immunology*; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000276:immunology; D008297:Male; D051379:Mice; D016513:Mice, SCID; D009101:Multiple Myeloma / Q000276:immunology*; D053722:Receptors, Interleukin-17 / Q000235:genetics / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000166:cytology / Q000276:immunology*; D018417:Th1 Cells / Q000166:cytology / Q000276:immunology
chemical_list: D016207:Cytokines; D020381:Interleukin-17; D053722:Receptors, Interleukin-17
references.citation: Nature. 2006 May 11;441(7090):235-8
references.pmid: 16648838
references.citation: Nature. 2006 Jul 27;442(7101):461-5
references.pmid: 16688182
references.citation: EMBO J. 2001 Oct 1;20(19):5332-41
references.pmid: 11574464
references.citation: Arthritis Rheum. 2003 Apr;48(4):993-1001
references.pmid: 12687541
references.citation: Proc Natl Acad Sci U S A. 2006 May 23;103(21):8137-42
references.pmid: 16698929
references.citation: Nat Med. 2008 Mar;14(3):275-81
references.pmid: 18264110
references.citation: Br J Haematol. 2003 Jun;121(6):842-8
references.pmid: 12786794
references.citation: J Immunol. 1986 Apr 1;136(7):2348-57
references.pmid: 2419430
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15505-10
references.pmid: 18832156
references.citation: J Exp Med. 2008 Sep 29;205(10):2281-94
references.pmid: 18779348
references.citation: Nat Clin Pract Oncol. 2007 Jul;4(7):394-5
references.pmid: 17534287
references.citation: Hematol Oncol Clin North Am. 1997 Feb;11(1):51-69
references.pmid: 9081204
references.citation: J Intern Med. 2009 Jun;265(6):644-52
references.pmid: 19493058
references.citation: Blood. 1991 Oct 1;78(7):1770-80
references.pmid: 1832993
references.citation: J Exp Med. 1996 Jun 1;183(6):2593-603
references.pmid: 8676080
references.citation: Nat Med. 2008 Mar;14(3):282-9
references.pmid: 18264109
references.citation: Blood. 2003 Aug 15;102(4):1435-42
references.pmid: 12714512
references.citation: Blood. 2002 May 15;99(10):3756-62
references.pmid: 11986233
references.citation: Nat Rev Cancer. 2007 Aug;7(8):585-98
references.pmid: 17646864
references.citation: Blood. 2008 Nov 1;112(9):3696-703
references.pmid: 18698005
references.citation: Nat Immunol. 2007 Sep;8(9):950-7
references.pmid: 17676044
references.citation: Immunity. 1995 Dec;3(6):811-21
references.pmid: 8777726
references.citation: Cancer Res. 2007 Dec 15;67(24):11970-9
references.pmid: 18089828
references.citation: Blood. 2009 Aug 6;114(6):1141-9
references.pmid: 19470694
references.citation: J Exp Med. 2008 Jul 7;205(7):1543-50
references.pmid: 18591412
references.citation: Blood. 1996 Apr 15;87(8):3297-306
references.pmid: 8605346
references.citation: Immunity. 2005 Mar;22(3):285-94
references.pmid: 15780986
references.citation: J Immunol. 2005 Nov 15;175(10):6676-85
references.pmid: 16272323
references.citation: Nat Immunol. 2008 Jan;9(1):34-41
references.pmid: 18059273
references.citation: Nature. 2006 May 11;441(7090):231-4
references.pmid: 16648837
references.citation: Br J Haematol. 2001 Jun;113(4):1051-9
references.pmid: 11442502
references.citation: Blood. 2008 Oct 1;112(7):2878-85
references.pmid: 18669891
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19845-50
references.pmid: 19057011
references.citation: Eur J Intern Med. 2006 Oct;17(6):412-6
references.pmid: 16962948
references.citation: Immunity. 2004 Aug;21(2):241-54
references.pmid: 15308104
references.citation: Immunity. 2004 Oct;21(4):467-76
references.pmid: 15485625
references.citation: Blood. 2001 Nov 1;98(9):2817-27
references.pmid: 11675356
references.citation: Clin Cancer Res. 2009 Jun 15;15(12):4028-37
references.pmid: 19509164
references.citation: Cytokine. 2008 Aug;43(2):103-4
references.pmid: 18585926
references.citation: Cancer Res. 2003 Sep 15;63(18):5850-8
references.pmid: 14522909
references.citation: Nature. 2008 May 1;453(7191):106-9
references.pmid: 18362914
references.citation: Nat Immunol. 2007 Jun;8(6):630-8
references.pmid: 17450144
references.citation: Nat Rev Rheumatol. 2009 Jun;5(6):325-31
references.pmid: 19434074
references.citation: Immunity. 2009 Nov 20;31(5):787-98
references.pmid: 19879162
references.citation: Nat Immunol. 2007 Sep;8(9):942-9
references.pmid: 17676045
references.citation: Hematol Oncol. 2003 Mar;21(1):33-42
references.pmid: 12605421
references.citation: Blood. 2008 Apr 1;111(7):3388-94
references.pmid: 18239085
references.citation: Nat Immunol. 2007 Apr;8(4):369-77
references.pmid: 17351619
references.citation: Immunity. 2007 Oct;27(4):660-9
references.pmid: 17919942
references.citation: Cell. 2006 Sep 22;126(6):1121-33
references.pmid: 16990136